Form: 3

Initial statement of beneficial ownership of securities

October 15, 2026

Documents

SEC Form 3
FORM 3 UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

INITIAL STATEMENT OF BENEFICIAL OWNERSHIP OF SECURITIES


Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940
OMB APPROVAL
OMB Number: 3235-0104
Estimated average burden
hours per response: 0.5
1. Name and Address of Reporting Person*
Moore-Pilon Sandra Jean
(Last) (First) (Middle)
C/O RH
15 KOCH ROAD, SUITE K
(Street)
CORTE MADERA CA 94925
(City) (State) (Zip)
2. Date of Event Requiring Statement (Month/Day/Year)
10/08/2026 		3. Issuer Name and Ticker or Trading Symbol
RH [ RH ]
4. Relationship of Reporting Person(s) to Issuer
(Check all applicable)
Director 10% Owner
X Officer (give title below) Other (specify below)
SEE REMARKS
5. If Amendment, Date of Original Filed (Month/Day/Year)
6. Individual or Joint/Group Filing (Check Applicable Line)
X Form filed by One Reporting Person
Form filed by More than One Reporting Person
Table I - Non-Derivative Securities Beneficially Owned
1. Title of Security (Instr. 4) 2. Amount of Securities Beneficially Owned (Instr. 4) 3. Ownership Form: Direct (D) or Indirect (I) (Instr. 5) 4. Nature of Indirect Beneficial Ownership (Instr. 5)
Common Stock 783 D
Table II - Derivative Securities Beneficially Owned
(e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 4) 2. Date Exercisable and Expiration Date (Month/Day/Year) 3. Title and Amount of Securities Underlying Derivative Security (Instr. 4) 4. Conversion or Exercise Price of Derivative Security 5. Ownership Form: Direct (D) or Indirect (I) (Instr. 5) 6. Nature of Indirect Beneficial Ownership (Instr. 5)
Date Exercisable Expiration Date Title Amount or Number of Shares
Stock Option (Right to Buy) (1) 06/22/2028 Common Stock 8,000 151.35 D
Stock Option (Right to Buy) (2) 04/28/2030 Common Stock 8,000 154.82 D
Stock Option (Right to Buy) (3) 06/08/2033 Common Stock 5,000 264.27 D
Stock Option (Right to Buy) (4) 04/10/2034 Common Stock 5,000 267.09 D
Stock Option (Right to Buy) (5) 04/12/2035 Common Stock 10,000 164.62 D
Stock Option (Right to Buy) (6) 04/13/2036 Common Stock 20,000 130.72 D
Stock Option (Right to Buy) (7) 07/22/2036 Common Stock 40,000 166.08 D
Explanation of Responses:
1. This option award is fully vested and exercisable.
2. This option award is vested and exercisable with respect to 6,400 of the shares and will vest and become exercisable with respect to an additional 1,600 shares on April 29, 2027, subject to continuous service.
3. This option award is vested and exercisable with respect to 1,500 of the shares and will vest and become exercisable with respect to an additional 750 shares on June 9, 2027, an additional 750 shares on June 9, 2028, an additional 1,000 shares on June 9, 2029, and an additional 1,000 shares on June 9, 2030, subject to continuous service.
4. This option award is vested and exercisable with respect to 1,000 of the shares and will vest and become exercisable with respect to an additional 500 shares on April 11, 2027, an additional 750 shares on April 11, 2028, an additional 750 shares on April 11, 2029, an additional 1,000 shares on April 11, 2030, and an additional 1,000 shares on April 11, 2031, subject to continuous service.
5. This option award is vested and exercisable with respect to 1,429 of the shares and will vest and become exercisable with respect to an additional 1,428 shares on April 13, 2027, an additional 1,429 shares on April 13, 2028, an additional 1,428 shares on April 13, 2029, an additional 1,429 shares on April 13, 2030, an additional 1,428 shares on April 13, 2031, and an additional 1,429 shares on April 13, 2032, subject to continuous service.
6. This option award will vest and become exercisable with respect to 2,000 shares on April 14, 2027, an additional 2,000 shares on April 14, 2028, an additional 2,000 shares on April 14, 2029, an additonal 3,000 shares on April 14, 2030, an additional 3,000 shares on April 14, 2031, and additional 4,000 shares on April 14, 2032, and an additional 4,000 shares on April 14, 2033, subject to continuous service.
7. This option award will vest and become exercisable with respect to 5,715 shares on July 23, 2027, an additional 5,715 shares on July 23, 2028, an additional 5,714 shares on July 23, 2029, an additonal 5,714 shares on July 23, 2030, an additional 5,714 shares on July 23, 2031, and additional 5,714 shares on July 23, 2032, and an additional 5,714 shares on July 23, 2033, subject to continuous service.
Remarks:
Chief Customer Experience & Values Officer
/s/ Jill Falor, Attorney-in-Fact 10/15/2026
** Signature of Reporting Person Date

Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.

* If the form is filed by more than one reporting person, see Instruction 5 (b)(v).

** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).

Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.

Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.